Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.

Item Type:Article
Title:Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study.
Creators Name:Launspach, M. and Temel, D. and Ohlendorf, E. and Zirngibl, F. and Materne, B. and Oevermann, L. and Deubzer, H.E. and Henssen, A.G. and Künkele, A. and Hundsdörfer, P. and von Bernuth, H. and Pruß, A. and Eggert, A. and von Stackelberg, A. and Lang, P. and Schulte, J.H.
Abstract:Not available.
Source:Haematologica
ISSN:0390-6078
Publisher:Ferrata Storti Foundation
Date:22 September 2022
Official Publication:https://doi.org/10.3324/haematol.2022.281134
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library